JEAN SIMPSON: Open Payments
NPI 1538548904 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 16 payments from 6 companies in 2025. Trend: 2023 $614 · 2024 $615 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $173 |
| ABBVIE INC. | 4 | $164 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| Brainsway USA INC | 1 | $47 |
| Alkermes, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, SPRAVATO, Deep TMS System, ARISTADA, ABILIFY MAINTENA, REXULTI, UZEDY.
Industry payments across LA — which companies pay providers there.
